Mera Pharmaceuticals Stock Probability of Future Pink Sheet Price Finishing Over 1.0E-4
| MRPI Stock | USD 0.0001 0.00 0.00% |
Mera |
Mera Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mera Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mera Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mera Pharmaceuticals generated a negative expected return over the last 90 days | |
| Mera Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Mera Pharmaceuticals currently holds 299.14 K in liabilities. Mera Pharmaceuticals has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mera Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Mera Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mera Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mera to invest in growth at high rates of return. When we think about Mera Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 302.62 K. Net Loss for the year was (5.58 K) with profit before overhead, payroll, taxes, and interest of 286.36 K. | |
| Mera Pharmaceuticals currently holds about 4.32 K in cash with (71.84 K) of positive cash flow from operations. |
Mera Pharmaceuticals Technical Analysis
Mera Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Mera Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mera Pharmaceuticals. In general, you should focus on analyzing Mera Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Mera Pharmaceuticals Predictive Forecast Models
Mera Pharmaceuticals' time-series forecasting models is one of many Mera Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mera Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Mera Pharmaceuticals
Checking the ongoing alerts about Mera Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mera Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mera Pharmaceuticals generated a negative expected return over the last 90 days | |
| Mera Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Mera Pharmaceuticals currently holds 299.14 K in liabilities. Mera Pharmaceuticals has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mera Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Mera Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mera Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mera to invest in growth at high rates of return. When we think about Mera Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 302.62 K. Net Loss for the year was (5.58 K) with profit before overhead, payroll, taxes, and interest of 286.36 K. | |
| Mera Pharmaceuticals currently holds about 4.32 K in cash with (71.84 K) of positive cash flow from operations. |
Other Information on Investing in Mera Pink Sheet
Mera Pharmaceuticals financial ratios help investors to determine whether Mera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mera with respect to the benefits of owning Mera Pharmaceuticals security.